These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33364855)

  • 1. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.
    Supuran CT
    J Exp Pharmacol; 2020; 12():603-617. PubMed ID: 33364855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.
    Angeli A; Carta F; Nocentini A; Winum JY; Zalubovskis R; Akdemir A; Onnis V; Eldehna WM; Capasso C; Simone G; Monti SM; Carradori S; Donald WA; Dedhar S; Supuran CT
    Metabolites; 2020 Oct; 10(10):. PubMed ID: 33066524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.
    Supuran CT
    Metabolites; 2017 Sep; 7(3):. PubMed ID: 28926956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1197-1208. PubMed ID: 34865569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site.
    Singh S; Lomelino CL; Mboge MY; Frost SC; McKenna R
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29710858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
    Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.
    Mboge MY; McKenna R; Frost SC
    Top Anticancer Res; 2015; 5():3-42. PubMed ID: 30272043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA IX stratification based on cancer treatment: a patent evaluation of US2016/0002350.
    Supuran CT
    Expert Opin Ther Pat; 2016 Oct; 26(10):1105-1109. PubMed ID: 27575256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
    Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on anticancer drug development and delivery targeting carbonic anhydrase IX.
    Kazokaitė J; Aspatwar A; Parkkila S; Matulis D
    PeerJ; 2017; 5():e4068. PubMed ID: 29181278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
    Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
    Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
    J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT; Winum JY
    Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
    Ozensoy Guler O; Arslan O; Kockar F
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.